A detailed history of Canton Hathaway, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Canton Hathaway, LLC holds 2,085 shares of LLY stock, worth $1.91 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,085
Previous 2,085 -0.0%
Holding current value
$1.91 Million
Previous $1.62 Million 16.4%
% of portfolio
0.52%
Previous 0.44%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $35,532 - $47,536
-60 Reduced 2.8%
2,085 $1.62 Million
Q1 2022

Apr 12, 2022

BUY
$234.69 - $291.66 $107,957 - $134,163
460 Added 27.3%
2,145 $614,000
Q4 2021

Jan 06, 2022

BUY
$224.85 - $279.04 $224,850 - $279,040
1,000 Added 145.99%
1,685 $465,000
Q3 2021

Oct 14, 2021

BUY
$221.6 - $272.71 $40,996 - $50,451
185 Added 37.0%
685 $158,000
Q3 2019

Oct 11, 2019

BUY
$106.79 - $116.16 $50,191 - $54,595
470 Added 1566.67%
500 $56,000
Q2 2019

Jul 15, 2019

BUY
$110.79 - $129.32 $3,323 - $3,879
30 New
30 $3,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $871B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Canton Hathaway, LLC Portfolio

Follow Canton Hathaway, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canton Hathaway, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Canton Hathaway, LLC with notifications on news.